erm gene distribution among Norwegian Bacteroides isolates and evaluation of phenotypic tests to detect inducible clindamycin resistance in Bacteroides species

Anaerobe

Volumn 47, Issue , 2017, Pages 226-232

  Johnsen, Bjørn Odd ^a   Handal, Nina ^a   Meisal, Roger ^a   Bjørnholt, Jørgen Vildershøj ^b,c   Gaustad, Peter ^c,d   Leegaard, Truls Michael ^a,c  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d Fürst Medical Laboratory   (Norway)

Author keywords

Bacteroides species; Clindamycin resistance; erm genes; Inducible resistance; Phenotypic detection

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; ANTIINFECTIVE AGENT; METHYLTRANSFERASE; RRNA (ADENOSINE-O-2'-)METHYLTRANSFERASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BACTEROIDES; BACTEROIDES CACCAE; BACTEROIDES CELLULOSILYTICUS; BACTEROIDES DOREI; BACTEROIDES FAECIS; BACTEROIDES FRAGILIS; BACTEROIDES INTESTINALIS; BACTEROIDES OVATUS; BACTEROIDES SALYERSIAE; BACTEROIDES STERCORIS; BACTEROIDES TECTUS; BACTEROIDES THETAIOTAOMICRON; BACTEROIDES UNIFORMIS; BACTEROIDES VULGATUS; BACTEROIDES XYLANISOLVEN; CONTROLLED STUDY; DISK DIFFUSION; EPSILOMETER TEST; ERM GENE; INCUBATION TIME; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; BACTEROIDES INFECTION; EVALUATION STUDY; GENETICS; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; NORWAY; PROCEDURES; TRANSCRIPTION INITIATION;

ANTI-BACTERIAL AGENTS; BACTEROIDES; BACTEROIDES INFECTIONS; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; HOSPITALS; HUMANS; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; NORWAY; SENSITIVITY AND SPECIFICITY; TRANSCRIPTIONAL ACTIVATION;

EID: 85021070434     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2017.06.004     Document Type: Article

References (37)

1. Nagy, E., Urban, E., Nord, C.E., the ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. Clin. Microbiol. Infect. 17:3 (2011 Mar), 371–379, 10.1111/j.1469-0691.2010.03256.x.
2. Wexler, H.M., Bacteroides: the good, the bad, and the nitty-gritty. Clin. Microbiol. Rev. 20:4 (2007 Oct), 593–621, 10.1128/CMR.00008-07.
3. Snydman, D.R., Jacobus, N.V., McDermott, L.A., et al. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob. Agents Chemother. 51:5 (2007 May), 1649–1655, 10.1128/AAC.01435-06.
4. Brook, I., Antimicrobial treatment of anaerobic infections. Expert Opin. Pharmacother. 12:11 (2011 Aug), 1691–1707, 10.1517/14656566.2011.576672.
5. Hecht, D.W., Prevalence of antibiotic resistance in anaerobic bacteria: worrisome developments. Clin. Infect. Dis. 39:1 (2004 Jul 1), 92–97, 10.1086/421558.
6. Roberts, M.C., Acquired tetracycline and/or macrolide-lincosamides-streptogramin resistance in anaerobes. Anaerobe 9:2 (2003 Apr), 63–69, 10.1016/S1075-9964(03)00058-1.
7. Eitel, Z., Soki, J., Urban, E., Nagy, E., ESCMID Study Group on Anaerobic Infection. The prevalence of antibiotic resistance genes in Bacteroides fragilis group strains isolated in different European countries. Anaerobe 21 (2013 Jun), 43–49, 10.1016/j.anaerobe.2013.03.001.
8. Szekely, E., Eitel, Z., Molnar, S., Szasz, I.E., Bilca, D., Soki, J., Analysis of Romanian Bacteroides isolates for antibiotic resistance levels and the corresponding antibiotic resistance genes. Anaerobe 31 (2015 Feb), 11–14, 10.1016/j.anaerobe.2014.09.001.
9. Roberts, M.C., Tetracycline and MLS Nomenclature. (Most tables updated February 2017), 2017 Retrieved 09-04-2017 from http://faculty.washington.edu/marilynr/.
10. Shoemaker, N.B., Vlamakis, H., Hayes, K., Salyers, A.A., Evidence for extensive resistance gene transfer among Bacteroides spp. and among Bacteroides and other genera in the human colon. Appl. Environ. Microbiol. 67:2 (2001 Feb), 561–568, 10.1128/AEM.67.2.561-568.2001.
11. Roberts, M.C., Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes. FEMS Microbiol. Lett. 282:2 (2008 May), 147–159, 10.1111/j.1574-6968.2008.01145.x.
12. Chung, W.O., Werckenthin, C., Schwarz, S., Roberts, M.C., Host range of the ermF rRNA methylase gene in bacteria of human and animal origin. J. Antimicrob. Chemother. 43:1 (1999 Jan), 5–14, 10.1093/jac/43.1.5.
13. Leclercq, R., Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34:4 (2002 Feb), 482–492, 10.1086/324626.
14. Leclercq, R., Canton, R., Brown, D.F., et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin. Microbiol. Infect. 19:2 (2013 Feb), 141–160, 10.1111/j.1469-0691.2011.03703.x.
15. Reig, M., Campello, M.G., Baquero, F., Inducible macrolides-lincosamides-streptogramin B resistance in Bacteroides species. Antimicrob. Agents Chemother. 31:4 (1987 Apr), 665–666.
16. Reig, M., Moreno, A., Baquero, F., Resistance of Peptostreptococcus spp. to macrolides and lincosamides: inducible and constitutive phenotypes. Antimicrob. Agents Chemother. 36:3 (1992 Mar), 662–664.
17. Reig, M., Baquero, F., Selection of constitutively resistant mutants of inducible clindamycin-resistant Bacteroides vulgatus. Eur. J. Clin. Microbiol. Infect. Dis. 8:8 (1989 Aug), 711–715.
18. Justesen, U.S., Wistedt, A., Skaare, D., NordicAST. Anaerobe Bakterier Og Resistens (Translated from Danish: Anaerobic Bacteria and Resistance). Version 1.2. (Updated 13-11-2015), 2015 Retrieved 21-11-2016 from http://www.nordicast.org/d/2548?store_referer=true.
19. BioMerieux, S.A., E-test application guide 16273B en. (Updated 7-2012), 2012 Retrieved 24-10-2016 from http://www.biomerieux-usa.com/sites/subsidiary_us/files/supplementary_inserts_-_16273_-_b_-_en_-_eag_-_etest_application_guide-3.pdf.
20. Pierard, D., De, M.A., Rosseel, P., Lauwers, S., Use of the E-test for determining antimicrobial susceptibility of anaerobic bacteria. Pathol. Biol. Paris. 44:5 (1996 May), 358–362.
21. Citron, D.M., Susceptibility testing of anaerobic bacteria: a review of current methods and future prospects. Antimicrob. Newsl. 8 (1992 Aug), 53–64, 10.1016/0738-1751(92)90019-7.
22. Bolmstrom, A., Susceptibility testing of anaerobes with Etest. Clin. Infect. Dis. 16:Suppl 4 (1993 Jun), S367–S370.
23. Biodisk, A.B., Etest(R) for art of anaerobes. Pamphlet, 2000, M0000222–M786.
24. Kangaba, A.A., Saglam, F.Y., Tokman, H.B., Torun, M., Torun, M.M., The prevalence of enterotoxin and antibiotic resistance genes in clinical and intestinal Bacteroides fragilis group isolates in Turkey. Anaerobe 35:Pt B (2015 Oct), 72–76, 10.1016/j.anaerobe.2015.07.008.
25. Quesada-Gomez, C., Rodriguez-Cavallini, E., Rodriguez, C., Scarce detection of mobile erm genes associated with tetQ in Bacteroides and Parabacteroides from Costa Rica. Anaerobe 21 (2013 Jun), 18–21 http://dx.doi.org/10.1016/j.anaerobe.2013.03.006.
26. Handal, N., Jørgensen, S.B., Tunsjø, H.S., Johnsen, B.O., Leegaard, T.M., Anaerobic blood culture isolates in a Norwegian university hospital: identification by MALDI-TOF MS vs 16S rRNA sequencing and antimicrobial susceptibility profiles. APMIS 123:9 (2015 Sep), 749–758, 10.1111/apm.12410.
27. The European Committee on Antimicrobial Susceptibility Testing, Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 6.0. (Updated 01-01-2016), 2016 Retrieved 26-10-2016 from http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_6.0_Breakpoint_table.pdf.
28. Littauer, P., Sangvik, M., Caugant, D.A., Hoiby, E.A., Simonsen, G.S., Sundsfjord, A., Molecular epidemiology of macrolide-resistant isolates of Streptococcus pneumoniae collected from blood and respiratory specimens in Norway. J. Clin. Microbiol. 43:5 (2005 May), 2125–2132, 10.1128/JCM.43.5.2125-2132.2005.
29. Hartmeyer, G.N., Soki, J., Nagy, E., Justesen, U.S., Multidrug-resistant Bacteroides fragilis group on the rise in Europe?. J. Med. Microbiol. 61:Pt 12 (2012 Dec), 1784–1788, 10.1099/jmm.0.049825-0.
30. Aldridge, K.E., Ashcraft, D., Cambre, K., Pierson, C.L., Jenkins, S.G., Rosenblatt, J.E., Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrob. Agents Chemother. 45:4 (2001 Apr), 1238–1243, 10.1128/AAC.45.4.1238-1243.2001.
31. Kuper, K.M., Boles, D.M., Mohr, J.F., Wanger, A., Antimicrobial susceptibility testing: a primer for clinicians. Pharmacotherapy 29:11 (2009 Nov), 1326–1343, 10.1592/phco.29.11.1326.
32. Lewis, J.S., Jorgensen, J.H., Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned?. Clin. Infect. Dis. 40:2 (2005 Jan), 280–285, 10.1086/426894.
33. Lewis, J.S., Lepak, A.J., Thompson, G.R. III, et al. Failure of clindamycin to eradicate infection with beta-hemolytic streptococci inducibly resistant to clindamycin in an animal model and in human infections. Antimicrob. Agents Chemother. 58:3 (2014 Mar), 1327–1331, 10.1128/AAC.01877-13.
34. Kommedal, O., Nystad, T.W., Bolstad, B., Digranes, A., Antibiotic susceptibility of blood culture isolates of anaerobic bacteria at a Norwegian university hospital. APMIS 115:8 (2007 Aug), 956–961, 10.1111/j.1600-0463.2007.apm_537.x.
35. Citron, D.M., Ostovari, M.I., Karlsson, A., Goldstein, E.J., Evaluation of the E test for susceptibility testing of anaerobic bacteria. J. Clin. Microbiol. 29:10 (1991 Oct), 2197–2203.
36. Reig, M., Fernandez, M.C., Ballesta, J.P., Baquero, F., Inducible expression of ribosomal clindamycin resistance in Bacteroides vulgatus. Antimicrob. Agents Chemother. 36:3 (1992 Mar), 639–642.
37. The European Committee on Antimicrobial Susceptibility Testing, EUCAST Expert Rules V. 3.1 Intrinsic Resistance and Exceptional Phenotypes Tables. (Updated 26-09-2016), 2016 Retrieved 15-10-2016 from http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Expert_Rules/Expert_rules_intrinsic_exceptional_V3.1.pdf.